Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma. [electronic resource]
Producer: 20020307Description: 268-75 p. digitalISSN:- 0887-6924
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bleomycin -- administration & dosage
- Carmustine -- administration & dosage
- Chromosomes, Human, Pair 3 -- genetics
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- DNA Mutational Analysis
- DNA, Neoplasm -- genetics
- DNA-Binding Proteins -- genetics
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Genes, bcl-2
- Humans
- Life Tables
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Melphalan -- administration & dosage
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Proteins -- genetics
- Neoplasm Staging
- Point Mutation
- Prednisolone -- administration & dosage
- Prednisone -- administration & dosage
- Prognosis
- Proto-Oncogene Mas
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins c-bcl-6
- Proto-Oncogenes
- Transcription Factors -- genetics
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.